DBV Technologies (DBVT) Interest Expenses (2018 - 2026)
DBV Technologies (DBVT) posted quarterly Interest Expenses of $8.9 million for Q2 2026, down 2.38% year-on-year from $9.1 million in Q2 2025, and up 25.35% on a QoQ basis from $7.1 million in Q1 2026.
DBV Technologies (DBVT) Interest Expenses (2018 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Interest Expenses for 9 consecutive years, with $8.9 million the latest figure, recorded in Q2 2026.
- Quarterly Interest Expenses fell 2.38% year-over-year to $8.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.9 million (down 2.38% YoY) and the FY2025 annual result came in at $365.8 million, up 12.52% from the prior year.
- Interest Expenses rose to $8.9 million in Q2 2026 per DBVT's latest filing, from $7.1 million in the prior quarter.
- Over the last five years, Interest Expenses for DBVT reached as high as $9.1 million in Q2 2025 and fell as low as -$88000.0 in Q4 2024.
- A 5-year average of $3.5 million and a median of $1.7 million in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses surged 1847.06% — and 2024, when it plunged 116.12%.
- Year by year, Interest Expenses stood at $662000.0 in 2022, then fell by 17.52% to $546000.0 in 2023, then sank by 116.12% to -$88000.0 in 2024, then soared by 398.86% to $263000.0 in 2025, then soared by 3284.03% to $8.9 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $8.9 million, $7.1 million, and $263000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 8.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.90 Mn |
| Jun 30, 2026 | 8.90 Mn |
| Mar 31, 2026 | 7.10 Mn |
| Mar 31, 2026 | 7.10 Mn |
| Dec 31, 2025 | 263,000.00 |
| Dec 31, 2025 | 263,000.00 |
| Sep 30, 2025 | 9.02 Mn |
| Sep 30, 2025 | 9.02 Mn |
| Jun 30, 2025 | 9.12 Mn |
| Jun 30, 2025 | 9.12 Mn |
| Mar 31, 2025 | 8.68 Mn |
| Mar 31, 2025 | 8.68 Mn |
| Dec 31, 2024 | -88,000.00 |
| Dec 31, 2024 | -88,000.00 |
| Sep 30, 2024 | 9.08 Mn |
| Sep 30, 2024 | 9.08 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.91 Mn |